Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$7.02 - $13.33 $91,618 - $173,969
-13,051 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$15.16 - $18.97 $197,853 - $247,577
13,051 New
13,051 $209,000
Q3 2020

Nov 13, 2020

SELL
$10.46 - $14.46 $4.61 Million - $6.37 Million
-440,551 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$12.0 - $16.13 $749,388 - $1.01 Million
-62,449 Reduced 12.42%
440,551 $6.5 Million
Q1 2020

May 14, 2020

BUY
$11.84 - $25.52 $1.54 Million - $3.32 Million
130,000 Added 34.85%
503,000 $6.79 Million
Q4 2019

Feb 14, 2020

BUY
$17.72 - $25.1 $1.15 Million - $1.63 Million
65,000 Added 21.1%
373,000 $9.02 Million
Q3 2019

Oct 31, 2019

SELL
$18.41 - $28.0 $1.43 Million - $2.18 Million
-77,800 Reduced 20.17%
308,000 $5.92 Million
Q2 2019

Jul 12, 2019

SELL
$28.97 - $48.21 $289,700 - $482,100
-10,000 Reduced 2.53%
385,800 $11.4 Million
Q1 2019

May 10, 2019

BUY
$36.32 - $49.25 $90,800 - $123,125
2,500 Added 0.64%
395,800 $18.8 Million
Q4 2018

Jan 31, 2019

BUY
$33.0 - $60.04 $2.09 Million - $3.8 Million
63,300 Added 19.18%
393,300 $14.2 Million
Q3 2018

Oct 19, 2018

BUY
$56.15 - $73.9 $1.4 Million - $1.85 Million
25,000 Added 8.2%
330,000 $20.3 Million
Q2 2018

Jul 11, 2018

BUY
$47.85 - $70.45 $2.15 Million - $3.17 Million
45,000 Added 17.31%
305,000 $20.6 Million
Q1 2018

May 18, 2018

BUY
$51.15 - $61.0 $6.65 Million - $7.93 Million
130,000 Added 100.0%
260,000 $14.1 Million
Q3 2017

Oct 24, 2017

BUY
$48.6 - $60.1 $6.32 Million - $7.81 Million
130,000
130,000 $6.32 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.